MoneyWorks4Me

Auro Laboratories - Quaterly Results

06 Feb 2024 Evaluate
The Revenue for the quarter ended  December 2023 of Rs. 179.78 millions grew by 15.07 % from Rs. 156.24 millions.Net Profit witnessed a 649.04% growth almost the double from Rs. 3.65 millions to Rs. 27.34  millions  of same quarter last year.OP of the company witnessed a marginal growth to 45.03 millions from 8.76 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 179.78 156.24 15.07 415.72 393.69 5.60 528.94 508.66 3.99
Other Income 4.23 4.28 -1.17 11.05 3.22 243.17 9.41 10.92 -13.83
PBIDT 45.03 8.76 414.04 93.67 23.64 296.24 53.33 57.17 -6.72
Interest 4.45 1.00 345.00 10.60 6.81 55.65 8.14 8.26 -1.45
PBDT 40.58 7.76 422.94 83.07 16.83 393.58 45.19 48.91 -7.61
Depreciation 2.70 2.70 0.00 8.10 7.70 5.19 10.74 10.17 5.60
PBT 37.88 5.06 648.62 74.97 9.13 721.14 34.45 38.74 -11.07
TAX 10.54 1.41 647.52 20.86 2.54 721.26 10.04 10.29 -2.43
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 -0.38 -107.89
PAT 27.34 3.65 649.04 54.11 6.59 721.09 24.41 28.45 -14.20
Equity 62.32 62.32 0.00 62.33 62.33 0.00 62.33 62.32 0.02
PBIDTM(%) 25.05 5.61 346.73 22.53 6.00 275.24 10.08 11.24 -10.29
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..